Open AccessCanadian Association of Gastroenterology Clinical Practice Guidelines: The Use of Tumour Necrosis Factor-Alpha Antagonist Therapy in Crohn’s Disease
Author(s) -
Daniel Sadowski,
Çharles N. Bernstein,
Alain Bitton,
Ken Croitoru,
Richard N. Fedorak,
Anne M. Griffiths,
the CAG Crohn’s Consensus Group
Publication year - 2009
Publication title -
canadian journal of gastroenterology
Language(s) - English
Resource type - Journals
eISSN - 1916-7237
pISSN - 0835-7900
DOI - 10.1155/2009/201430
Subject(s) - medicine , voting , infliximab , crohn's disease , disease , family medicine , intensive care medicine , political science , politics , law
Guidelines regarding the use of infliximab in Crohn's disease were previously published by the Canadian Association of Gastroenterology in 2004. However, recent clinical findings and drug developments warrant a review and update of these guidelines.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom